Semaglutide is a tolerable medication with a ~8% discontinuation rate and no risk of brain bleeds or necessity for IV infusion (compared to anti-amyloid drugs for AD patients)
A few popular brands tested their nootropics in some capacity, including Mind Lab Pro, Onnit, and Qualia
Keep detailed logs of readings and food intake
Timothy Garvey, of the Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA, who led the research
Make the change gradually over 12 weeks if possible to let your body adjust, and notify your PlexusDx provider about the new schedule
Semaglutide carries the most extensive clinical trial history of the three, including the previously cited 68-week trial reporting average weight reductions exceeding 14%, which makes it a common reference point for metabolic and receptor-signaling studies